FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Richard Gregory
 2. Date of Event Requiring Statement (Month/Day/Year)
09/14/2017		 3. Issuer Name and Ticker or Trading Symbol
Interpace Diagnostics Group, Inc. [IDXG]
(Last)
(First)
(Middle)
C/O INTERPACE DIAGNOSTICS GROUP, INC., 300 INTERPACE PARKWAY		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Commercial Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

PARSIPPANY, NJ 07054		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   (1) 10/14/2026 Common Stock 12,257 $ 1.6 D  
Stock Option (right to buy)   (2) 03/16/2027 Common Stock 17,134 $ 2.12 D  
Stock Appreciation Right   (3) 04/02/2019 Common Stock 3,742 $ 45.7 D  
Restricted Stock Units   (4)   (4) Common Stock 4,000 $ 0 D  
Stock Option (right to buy)   (5) 05/11/2027 Common Stock 50,269 $ 2.39 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Richard Gregory
C/O INTERPACE DIAGNOSTICS GROUP, INC.
300 INTERPACE PARKWAY
PARSIPPANY, NJ 07054		       Chief Commercial Officer  

Signatures

/s/ Gregory Richard 09/21/2017
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The reporting person was awarded 12,257 stock options, of which 11,236 options are currently exercisable and the remaining will vest on October 14, 2017.
(2) The reporting person was awarded 17,134 stock options, of which 8,566 options are currently exercisable and the remaining will vest ratably over the next six months.
(3) The reporting person was awarded 3,742 stock appreciation rights, of which all are immediately exercisable.
(4) The reporting person was awarded 4,000 restricted stock units, of which half will vest on February 26, 2018 and the remaining half on February 26, 2019. Upon vesting, the reporting person will receive a number of shares of common stock of Issuer equal to the number of restricted stock units vested.
(5) The reporting person was awarded 50,269 stock options, of which 16,756 options are currently exercisable and the remaining will vest ratably over the next eight months.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.